Suppr超能文献

扩张型心肌病患者的八年生存分析:治疗时代是否影响预后?

Eight-Year Survival Analysis of Patients With Dilated Cardiomyopathy: Does Treatment Era Affect Prognosis?

作者信息

Kucera Lukas, Chudý Martin, Danková Marcela, Goncalvesová Eva

机构信息

Department of Heart Failure and Heart Transplantation, Faculty of Medicine, Comenius University, Bratislava, SVK.

出版信息

Cureus. 2025 Jul 9;17(7):e87586. doi: 10.7759/cureus.87586. eCollection 2025 Jul.

Abstract

Background Dilated cardiomyopathy (DCM) is a leading cause of heart failure (HF). We retrospectively analyzed long-term survival in DCM and the impact of clinical factors on their prognosis. Methods This was a retrospective analysis of 622 DCM patients (484 men, 138 women). Survival was compared between the 2016-2019 and 2020-2023 cohorts. Results The mean age was similar between cohorts (54 ± 13 vs. 55 ± 13 years). Mean overall survival for the entire cohort was 84.1 ± 1.6 months (95% CI: 81.0-87.4). When analyzed by period, mean survival was 84.1 ± 2.0 months (95% CI: 80.3-87.9) for patients diagnosed between 2016 and 2019 and 53.4 ± 1.1 months (95% CI: 51.2-55.6) for those diagnosed between 2020 and 2023. The difference was not statistically significant (log-rank p = 0.856). The shorter mean survival in the later period reflects the limited follow-up time due to ongoing observation. In the 2020-2023 group, a higher proportion of patients were classified as New York Heart Association (NYHA) III/IV (56% vs. 48%, p = 0.036) and had larger ventricular diameters (left ventricular end-diastolic diameter (LVEDD): 68 ± 8 mm vs. 66 ± 7 mm, p = 0.001; right ventricle (RV): 36 ± 7 mm vs. 34 ± 6 mm, p = 0.001). Treatment with sodium-glucose cotransporter-2 inhibitors (SGLT2i) did not significantly affect survival. Multivariable analysis identified older age, NYHA class III/IV, chronic kidney disease (CKD) stages 3-5, diabetes, and N-terminal pro-B-type natriuretic peptide (NT-proBNP) >3000 ng/L as independent negative predictors, while female sex and overweight status were associated with better survival. Multivariable analysis identified older age, NYHA III/IV, CKD stages 3-5, diabetes, and NT-proBNP >3000 ng/L as independent negative predictors. Female sex and overweight status were associated with improved survival. Conclusions Survival in DCM patients remained stable across time periods, despite a higher-risk profile in recent years, potentially influenced by the COVID-19 pandemic.

摘要

背景 扩张型心肌病(DCM)是心力衰竭(HF)的主要病因。我们回顾性分析了DCM患者的长期生存率以及临床因素对其预后的影响。方法 这是一项对622例DCM患者(484例男性,138例女性)的回顾性分析。比较了2016 - 2019年队列和2020 - 2023年队列的生存率。结果 各队列的平均年龄相似(54±13岁 vs. 55±13岁)。整个队列的平均总生存期为84.1±1.6个月(95%置信区间:81.0 - 87.4)。按时间段分析时,2016年至2019年诊断的患者平均生存期为84.1±2.0个月(95%置信区间:80.3 - 87.9),2020年至2023年诊断的患者为53.4±1.1个月(95%置信区间:51.2 - 55.6)。差异无统计学意义(对数秩检验p = 0.856)。后期平均生存期较短反映了由于持续观察导致的随访时间有限。在2020 - 2023组中,更高比例的患者被归类为纽约心脏协会(NYHA)III/IV级(56% vs. 48%,p = 0.036),且心室直径更大(左心室舒张末期内径(LVEDD):68±8 mm vs. 66±7 mm,p = 0.001;右心室(RV):36±7 mm vs. 34±6 mm,p = 0.001)。钠-葡萄糖协同转运蛋白2抑制剂(SGLT2i)治疗对生存率无显著影响。多变量分析确定年龄较大、NYHA III/IV级、慢性肾脏病(CKD)3 - 5期、糖尿病以及N末端B型利钠肽原(NT-proBNP)>3000 ng/L为独立的负性预测因素,而女性性别和超重状态与更好的生存率相关。多变量分析确定年龄较大、NYHA III/IV级、CKD 3 - 5期、糖尿病以及NT-proBNP>3000 ng/L为独立的负性预测因素。女性性别和超重状态与生存率改善相关。结论 尽管近年来风险状况较高,可能受新冠疫情影响,但DCM患者的生存率在不同时间段保持稳定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验